Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 1
Submit an article Journal homepage
721
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort

Lydia C. T. BuerDepartment of Gastroenterology, Oslo University Hospital, Oslo, Norway; ;Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5942-9202View further author information
ORCID Icon,
Bjørn A. MoumDepartment of Gastroenterology, Oslo University Hospital, Oslo, Norway; ;Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; View further author information
,
Milada CvancarovaDepartment of Gastroenterology, Oslo University Hospital, Oslo, Norway; ;Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway; View further author information
,
David J. WarrenDepartment of Medical Biochemistry, Oslo University Hospital, Oslo, NorwayView further author information
,
Nils BolstadFaculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; ;Department of Medical Biochemistry, Oslo University Hospital, Oslo, NorwayView further author information
,
Asle W. MedhusDepartment of Gastroenterology, Oslo University Hospital, Oslo, Norway; View further author information
&
Marte L. HøivikDepartment of Gastroenterology, Oslo University Hospital, Oslo, Norway; View further author information
 show all
Pages 41-48 | Received 05 Sep 2018, Accepted 09 Nov 2018, Published online: 16 Jan 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Thea H. Wiken, Marte L. Høivik, Lydia Buer, David J. Warren, Nils Bolstad, Bjørn A. Moum, Karoline Anisdahl, Milada C. Småstuen & Asle W. Medhus. (2023) Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring. Scandinavian Journal of Gastroenterology 58:8, pages 863-873.
Read now
Sara Kolehmainen, Tero Ylisaukko-oja, Jari Jokelainen, Mirkka Koivusalo, T. Sakari Jokiranta & Taina Sipponen. (2021) Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting. Scandinavian Journal of Gastroenterology 56:8, pages 906-913.
Read now

Articles from other publishers (7)

Fabio Salvatore Macaluso, Marco Ventimiglia & Ambrogio Orlando. (2023) Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies. Journal of Crohn's and Colitis.
Crossref
Isabella Visuri, Carl Eriksson, Sara Karlqvist, Byron Lykiardopoulos, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, Daniel Bergemalm, Henrik Hjortswang & Jonas Halfvarson. (2023) Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study. Therapeutic Advances in Gastroenterology 16, pages 175628482311749.
Crossref
Manar Shmais, Miguel Regueiro & Jana G. Hashash. (2022) Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?. Inflammatory Intestinal Diseases 7:1, pages 50-58.
Crossref
Fabio Salvatore Macaluso, Walter Fries, Sara Renna, Anna Viola, Marco Muscianisi, Maria Cappello, Laura Guida, Sebastiano Siringo, Salvatore Camilleri, Serena Garufi, Antonino Carlo Privitera, Nunzio Belluardo, Emiliano Giangreco, Carmelo Bertolami, Roberto Vassallo, Giulia Rizzuto, Rosalba Orlando, Marco Ventimiglia & Ambrogio Orlando. (2020) Effectiveness and safety of vedolizumab in biologically naïve patients: A real‐world multi‐centre study. United European Gastroenterology Journal 8:9, pages 1045-1055.
Crossref
Lorenzo Bertani, Gian Paolo Caviglia, Luca Antonioli, Rinaldo Pellicano, Sharmila Fagoonee, Marco Astegiano, Giorgio Maria Saracco, Elisabetta Bugianesi, Corrado Blandizzi, Francesco Costa & Davide Giuseppe Ribaldone. (2020) Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases. Journal of Clinical Medicine 9:5, pages 1323.
Crossref
Birgit Terjung, Renate Schmelz, Robert Ehehalt, Jochen Klaus, Jana Knop, Sabine Schwind, Thomas Wilke & Andreas Stallmach. (2020) Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review. Therapeutic Advances in Gastroenterology 13, pages 175628482095259.
Crossref
Konstantinos Papamichael & Adam S. Cheifetz. (2019) Therapeutic drug monitoring in inflammatory bowel disease. Current Opinion in Gastroenterology 35:4, pages 302-310.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.